Dyadic International, Inc. (NASDAQ: DYAI) is a biotechnology company focused on the efficient, large-scale production of proteins for human and animal vaccines, therapeutics, and non-pharmaceutical ...
Rise in number of surgical procedures and rise in use of plasma derived albumin in drug development drive the growth of the global albumin market. David Correa Allied Market Research +1 800-792-5285 ...
Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).